| 47.28 0 (0%) | 04-24 15:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
PPD, Inc. delivers a full spectrum of drug development services internationally, primarily catering to the biopharmaceutical industry. The company structures its operations across two core divisions: Clinical Development Services and Laboratory Services. Under its Clinical Development arm, PPD provides a diverse range of support, including initial product strategy and advisory services, early-stage development, end-to-end management of clinical trials from Phase II through Phase IV, techniques for accelerated patient recruitment, assistance with pre- and post-market approval processes, and various medical communication solutions. Furthermore, its Laboratory Services segment encompasses specialized capabilities such as bioanalytical analysis, biomarker identification, vaccine science expertise, adherence to Good Manufacturing Practice (GMP) guidelines, and centralized laboratory testing. The firm's extensive client base reaches beyond pharmaceutical and biotechnology companies to include manufacturers of medical devices, governmental organizations, and other participants throughout the industry. PPD, Inc. was established in 1985 and maintains its corporate headquarters in Wilmington, North Carolina.
Wed, 28 Feb 2024
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation - Dassault Systèmes
Sun, 09 Jul 2023
PPD - Carlyle
Thu, 09 Dec 2021
Thermo Fisher acquires clinical research services provider PPD for $17.4bn - Pharmaceutical Technology
Wed, 08 Dec 2021
'Business as usual:' Amid sale, PPD to keep its footprint in downtown Wilmington - Wilmington Star-News
Wed, 08 Dec 2021
Thermo Fisher Scientific Completes PPD Acquisition - Contract Pharma
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|